Causes of Elevated 17-Hydroxyprogesterone (17-OHP) Levels
The most common cause of elevated 17-OHP is 21-hydroxylase deficiency (accounting for ~95% of congenital adrenal hyperplasia cases), but you must also consider 11-hydroxylase deficiency, P450 oxidoreductase deficiency, 3β-hydroxysteroid dehydrogenase deficiency, and hormone-secreting adrenal or ovarian tumors 1.
Primary Causes by Category
Enzymatic Deficiencies (Most Common)
21-Hydroxylase Deficiency (Congenital Adrenal Hyperplasia)
- Represents approximately 95% of CAH cases 1
- Results from mutations in CYP21A2 gene encoding steroid 21-hydroxylase enzyme
- The enzyme normally converts 17-OHP to 11-deoxycortisol; deficiency causes 17-OHP accumulation
- Three clinical forms exist:
- Classic salt-wasting CAH (~75% of classic cases): Baseline 17-OHP typically >300 nmol/L (>10,000 ng/dL) 1
- Classic simple virilizing CAH: Similar 17-OHP elevation without aldosterone deficiency
- Nonclassic CAH (NCCAH): Baseline 17-OHP 6-300 nmol/L (200-10,000 ng/dL); post-ACTH stimulation 31-300 nmol/L (1,000-10,000 ng/dL) 1
Other Enzymatic Defects
- 11-hydroxylase deficiency: Also causes 17-OHP elevation and must be differentiated from 21-hydroxylase deficiency 1
- P450 oxidoreductase deficiency: Can present with elevated 17-OHP 1
- 3β-hydroxysteroid dehydrogenase deficiency: Extremely rare but can cause elevated 17-OHP in newborn screening despite absence of virilization 2
Tumor-Related Causes (Critical to Exclude)
Adrenal Tumors
- 17-OHP-secreting adrenal cortical adenomas: Can mimic NCCAH biochemically 3, 4, 5
- May show positive ACTH stimulation test responses similar to 21-hydroxylase deficiency 4, 6
- Consider when DHEAS >600 µg/dL (16,000 nmol/L), which suggests adrenal source 7
- Adrenal venous sampling can confirm lateralization of 17-OHP hypersecretion 5
- Unique presentation: Autoimmune adrenalitis with concurrent adrenal adenoma can cause elevated 17-OHP due to chronic ACTH stimulation unmasking low 21-hydroxylase expression in the tumor 3
Ovarian Tumors
- Steroid cell tumors, not otherwise specified (SCT-NOS): Can secrete 17-OHP 6
- Ovarian hyperthecosis: Associated with markedly elevated testosterone (>2× upper normal limit) and insulin resistance 7
- Urinary steroid profile can help localize 17-OHP source to ovaries versus adrenals 6
Diagnostic Algorithm
Initial Evaluation
- Obtain early morning baseline serum 17-OHP in symptomatic individuals 1
- Interpret baseline levels:
300 nmol/L (>10,000 ng/dL): Likely classic CAH
- 6-300 nmol/L (200-10,000 ng/dL): Likely NCCAH or tumor
- <6 nmol/L (<200 ng/dL): Likely unaffected or heterozygote 1
Confirmatory Testing
- Perform cosyntropin stimulation test with complete adrenocortical profile to differentiate enzyme defects and diagnose borderline cases 1
- Post-ACTH 17-OHP >300 nmol/L (>10,000 ng/dL): Classic CAH
- Post-ACTH 17-OHP 31-300 nmol/L (1,000-10,000 ng/dL): Likely NCCAH
- Post-ACTH 17-OHP <50 nmol/L (<1,666 ng/dL): Unaffected or heterozygote 1
Additional Workup When Indicated
- Measure DHEAS if testosterone is >2× upper normal limit 7
- DHEAS >600 µg/dL suggests adrenal tumor; obtain abdominal imaging urgently
- Check other steroids: 21-deoxycortisol, androstenedione, testosterone 1
- Assess aldosterone synthesis: Plasma renin activity and aldosterone-to-PRA ratio to differentiate salt-wasters from simple virilizers 1
When Tumor is Suspected
- Obtain imaging:
- Consider urinary steroid profile to localize 17-OHP source (ovarian vs. adrenal) 6
- Adrenal venous sampling may be needed to confirm lateralization in adrenal adenomas 5
Genetic Testing
- Reserve genotyping for equivocal cosyntropin test results or genetic counseling purposes 1
- Poor response to dexamethasone suppression in presumed NCCAH warrants gene mutation analysis 4
Critical Pitfalls to Avoid
- Don't assume all elevated 17-OHP is CAH: Tumors can mimic NCCAH biochemically, including positive ACTH stimulation responses 4, 6
- Don't overlook rare enzyme defects: 3β-hydroxysteroid dehydrogenase deficiency can present with elevated 17-OHP but without expected virilization 2
- Consider timing and medications: Assay conditions matter—check cycle timing, avoid thyroid hormones or estrogenic drugs that affect SHBG 7
- Heterozygotes can have mildly elevated 17-OHP after ACTH stimulation with overlap to unaffected subjects 1
- In women with infertility and elevated 17-OHP: If genetic testing is negative for 21-hydroxylase deficiency and steroid suppression fails, obtain imaging to exclude hormone-secreting tumors 4